MDR patterns of Turkish viridans-group streptococci
| VGS/Antimicrobial agent | Turkey (n = 119) |
Europe and Israel (n = 1,242) |
||
|---|---|---|---|---|
| % Intermediatea | %Ra | % Intermediatea | % Ra | |
| PEN | 32.8 | 37.0 | 19.6 | 5.0 |
| CRO | 5.8 | 36.5 | 3.9 | 3.3 |
| FEP | 10.9 | 30.3 | 4.6 | 3.6 |
| ERY | 5.9 | 53.8 | 4.0 | 28.3 |
| CC | 0.0 | 30.3 | 1.0 | 9.8 |
| LEV | 0.0 | 3.4 | 0.6 | 1.5 |
| TET | 3.4 | 51.3 | 2.0 | 28.9 |
| Q/D | 5.9 | 1.7 | 0.9 | 0.0 |
| Imipenem | − | 35.6b | − | 3.1b |
| MUP | − | 18.0c | − | 1.0c |
% based upon published CLSI S ranges (M100-S16)
% of isolates ≥1mg/L
% of isolates ≥16 mg/L.